Integra, set up by Yissum to invest in life science spinouts from Hebrew University of Jerusalem, has secured an initial tranche led by Temasek.
Integra Holdings, an Israel-based investment firm focused on life science spinouts from Hebrew University of Jerusalem, achieved a first close of a $25m funding round on Wednesday led by Temasek, the Singapore state-owned investment firm.
Temasek provided $15m for the round and was joined by VC firm Arie Capital, which committed $2m, and the Israeli Teachers’ and Kindergarten’s Study Funds, a government-backed vehicle run alongside the Israeli Teachers Union, that invested an undisclosed sum.
Founded in 2012 by Yissum, the university’s tech transfer office, Integra currently has stakes in 11 life science spinouts. The capital will go towards expanding Integra’s portfolio and further developing its existing assets.
Integra raised $10m from pharmaceuticals manufacturer Guangxi Wuzhou Zhongheng Group in 2014, according to deals database PitchBook, which followed a $7m round that included Hebrew University of Jerusalem.
The 2012 round was led by medical technology developer Invatech Health in 2012 and further included Israeli Teachers’ and Kindergarten’s Study Funds, private equity firm Halman-Aldubi Investment House and an unnamed angel investor.
Liana Patt, CEO of Integra Holdings, said: “I am proud to welcome Temasek and Arie Capital to our circle of investors.
“This strategic investment reinforces the global recognition of the Hebrew University’s exceptional contribution to life science innovations and Integra’s robust and growing portfolio.”
– A version of this story first appeared on our sister site, Global University Venturing.
